We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Elasticity Training Helps AI Diagnose Breast Cancer

By HospiMedica International staff writers
Posted on 22 Jul 2019
Teaching artificial intelligence (AI) algorithms to identify the ultrasound elastic heterogeneity of a tumor can be used to distinguish benign tumors from their malignant counterparts, according to a new study.

Researchers at the University of Southern California (USC; Los Angeles, USA), Rensselaer Polytechnic Institute (RPI; Troy, NY, USA), and other institutions created physics-based models that simulated varying levels of the two key ultrasound properties of a cancerous breast tumor - elastic heterogeneity and nonlinear elastic response. More...
They then used thousands of data inputs derived from the models in order to train a deep convolutional neural network (CNN) to classify tumors as malignant or benign.

A 5-layer CNN was trained with 8,000 samples for heterogeneity, and a 4-layer CNN was trained with 4,000 samples for nonlinear elasticity. When queried on additional synthetic images, the CNNs achieved classification accuracies of 99.7%−99.9%. The researchers then applied the nonlinear elasticity classifier, which was trained entirely using simulated data, in order to classify displacement images obtained from ten patients with breast lesions; the CNN correctly classified eight out of ten cases.

“The general consensus is these types of algorithms have a significant role to play, including from imaging professionals whom it will impact the most,” said senior author Professor Assad Oberai, PhD, of the USC department of aerospace and mechanical engineering. “However, these algorithms will be most useful when they do not serve as black boxes, but instead, a tool that helps guide radiologists to more accurate conclusions.”

Elastography relies on the generation of shear waves determined by the displacement of tissues induced by the force of a focused ultrasound beam or by external pressure. The shear waves are lateral waves, with a motion perpendicular to the direction of the generating force, traveling slowly, and are rapidly attenuated by tissue. The propagation velocity of the shear waves correlates with the elasticity of tissue.

Related Links:
University of Southern California
Rensselaer Polytechnic Institute


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A smartphone application displays a glucose concentration that was measured using the new sensor (Photo courtesy of Chuchu Chen and Yonghao Fu)

Wearable Device for Diabetics Could Replace Continuous Glucose Monitoring Systems

Monitoring blood glucose is essential for people with diabetes to prevent complications and maintain long-term health. Current continuous glucose monitoring systems require needles inserted under the skin,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.